Danling Gu

3.5k total citations · 1 hit paper
42 papers, 2.2k citations indexed

About

Danling Gu is a scholar working on Surgery, Genetics and Immunology. According to data from OpenAlex, Danling Gu has authored 42 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Surgery, 15 papers in Genetics and 12 papers in Immunology. Recurrent topics in Danling Gu's work include Pancreatic function and diabetes (14 papers), Diabetes and associated disorders (11 papers) and Chronic Lymphocytic Leukemia Research (7 papers). Danling Gu is often cited by papers focused on Pancreatic function and diabetes (14 papers), Diabetes and associated disorders (11 papers) and Chronic Lymphocytic Leukemia Research (7 papers). Danling Gu collaborates with scholars based in United States, China and United Kingdom. Danling Gu's co-authors include Nora Sarvetnick, Yue Dai, Inder M. Verma, Edward M. Schwarz, Wen‐Wei Zhang, Troy Krahl, Marc Arnush, Myung‐Shik Lee, Howard S. Fox and Glenn F. Pierce and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Blood.

In The Last Decade

Danling Gu

41 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression.

1995 515 citations Danling Gu, Nora Sarvetnick et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Danling Gu United States	20	1.0k	1.0k	862	501	387	42	2.2k
Valeria Sordi Italy	27	948 0.9×	659 0.6×	1.3k 1.5×	499 1.0×	484 1.3×	76	2.8k
Hetty L. DeVroom United States	19	613 0.6×	705 0.7×	733 0.9×	382 0.8×	394 1.0×	25	2.6k
Kelen Cristina Ribeiro Malmegrim Brazil	24	508 0.5×	406 0.4×	665 0.8×	239 0.5×	326 0.8×	63	2.0k
Valerie Gouon–Evans United States	22	1.4k 1.4×	355 0.3×	911 1.1×	720 1.4×	100 0.3×	32	3.0k
Julian Dyson United Kingdom	30	1.1k 1.0×	605 0.6×	670 0.8×	732 1.5×	177 0.5×	64	4.1k
Ji Lei China	23	741 0.7×	304 0.3×	477 0.6×	262 0.5×	194 0.5×	53	2.4k
Carol Tucker‐Burden United States	20	577 0.6×	290 0.3×	625 0.7×	257 0.5×	91 0.2×	29	2.2k
Mary Rieck United States	16	380 0.4×	860 0.8×	488 0.6×	353 0.7×	366 0.9×	22	2.3k
Joshua P. Frederick United States	23	2.6k 2.5×	304 0.3×	214 0.2×	818 1.6×	57 0.1×	32	3.6k
George Vassilopoulos Greece	16	945 0.9×	435 0.4×	539 0.6×	253 0.5×	27 0.1×	63	1.9k

Countries citing papers authored by Danling Gu

Since Specialization

Citations

This map shows the geographic impact of Danling Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danling Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danling Gu more than expected).

Fields of papers citing papers by Danling Gu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Danling Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danling Gu. The network helps show where Danling Gu may publish in the future.

Co-authorship network of co-authors of Danling Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Danling Gu. A scholar is included among the top collaborators of Danling Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Danling Gu. Danling Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Huang, Hui, Chenhua Li, Zhen Zhang, et al.. (2025). Radiation-induced glioblastoma stem cell-mediated T cell exhaustion via EGR1-Gal3-LAG3 axis in glioblastoma. Cancer Letters. 636. 218125–218125.

Li, Fanying, Kailin Yang, Xinya Gao, et al.. (2024). A peptide encoded by upstream open reading frame of MYC binds to tropomyosin receptor kinase B and promotes glioblastoma growth in mice. Science Translational Medicine. 16(767). eadk9524–eadk9524. 5 indexed citations

Wu, Zijuan, Danling Gu, Ruixin Wang, et al.. (2022). CircRIC8B regulates the lipid metabolism of chronic lymphocytic leukemia through miR199b-5p/LPL axis. Experimental Hematology and Oncology. 11(1). 51–51. 13 indexed citations

Gu, Danling, et al.. (2021). Targeting Bruton tyrosine kinase using non-covalent inhibitors in B cell malignancies. Journal of Hematology & Oncology. 14(1). 40–40. 67 indexed citations

Miao, Yi, Yixin Zou, Danling Gu, et al.. (2019). SF3B1 mutation predicts unfavorable treatment-free survival in Chinese chronic lymphocytic leukemia patients. Annals of Translational Medicine. 7(8). 176–176. 11 indexed citations

Hong, Ye, et al.. (2015). Use of taxane-containing induction chemotherapy in combination with concurrent chemoradiotherapy in Chinese patients with locally advanced nasopharyngeal carcinoma: a meta-analysis. OncoTargets and Therapy. 8. 3255–3255. 8 indexed citations

Mauze, Smita, Danling Gu, Derek Wiswell, et al.. (2015). The Role of Anti-Drug Antibodies in the Pharmacokinetics, Disposition, Target Engagement, and Efficacy of a GITR Agonist Monoclonal Antibody in Mice. Journal of Pharmacology and Experimental Therapeutics. 356(3). 574–586. 12 indexed citations

Chu, Haiyan, Danling Gu, Min Xu, et al.. (2013). A genetic variant in ERCC2 is associated with gastric cancer prognosis in a Chinese population. Mutagenesis. 28(4). 441–446. 15 indexed citations

Guzi, Timothy J., Kamil Paruch, Michael P. Dwyer, et al.. (2011). Targeting the Replication Checkpoint Using SCH 900776, a Potent and Functionally Selective CHK1 Inhibitor Identified via High Content Screening. Molecular Cancer Therapeutics. 10(4). 591–602. 135 indexed citations

10.

Chu, Huashuo, Maoyu Wang, Danling Gu, et al.. (2010). The MPO -463G>A polymorphism and cancer risk: a meta-analysis based on 43 case-control studies. Mutagenesis. 25(4). 389–395. 19 indexed citations

11.

Zhou, Pengfei, et al.. (2010). Mature B Cells Are Critical to T-cell-mediated Tumor Immunity Induced by an Agonist Anti-GITR Monoclonal Antibody. Journal of Immunotherapy. 33(8). 789–797. 29 indexed citations

12.

Gu, Danling, Isabella Atencio, David W. Kang, et al.. (2005). Recombinant adenovirus‐p21 attenuates proliferative responses associated with excessive scarring. Wound Repair and Regeneration. 13(5). 480–490. 4 indexed citations

13.

Gu, Danling, Thanh Nguyen, Ana María González-Castro, et al.. (2004). Adenovirus Encoding Human Platelet-Derived Growth Factor-B Delivered in Collagen Exhibits Safety, Biodistribution, and Immunogenicity Profiles Favorable for Clinical Use. Molecular Therapy. 9(5). 699–711. 68 indexed citations

14.

Gu, Danling, et al.. (2001). Cholecystokinin expression in the developing and regenerating pancreas and intestine. Journal of Endocrinology. 169(2). 233–240. 9 indexed citations

15.

Krahl, Troy, et al.. (2000). Expression of ErbB receptors during pancreatic islet development and regrowth. Journal of Endocrinology. 165(1). 67–77. 50 indexed citations

16.

Printz, Marie A., Ana María González, Mark R. Cunningham, et al.. (2000). Fibroblast Growth Factor 2-Retargeted Adenoviral Vectors Exhibit a Modified Biolocalization Pattern and Display Reduced Toxicity Relative to Native Adenoviral Vectors. Human Gene Therapy. 11(1). 191–204. 47 indexed citations

17.

Krahl, Troy, et al.. (1999). Transgenic expression of epidermal growth factor and keratinocyte growth factor in beta-cells results in substantial morphological changes. Journal of Endocrinology. 162(2). 167–175. 48 indexed citations

18.

Shelton, G. Diane, Nigel A. Calcutt, Robert S. Garrett, et al.. (1999). Necrotizing myopathy induced by overexpression of interferon-? in transgenic mice. Muscle & Nerve. 22(2). 156–165. 17 indexed citations

19.

Gu, Danling, Marc Arnush, & Nora Sarvetnick. (1997). Endocrine/Exocrine Intermediate Cells in Streptozotocin-Treated Ins-IFN-γ Transgenic Mice. Pancreas. 15(3). 246–250. 43 indexed citations

20.

Wogensen, Lise, et al.. (1994). Postnatal Anti-Interferon-γ Treatment Prevents Pancreatic Inflammation in Transgenic Mice with β-Cell Expression of Interferon-γ. Journal of Interferon Research. 14(3). 111–116. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact